This Article Full Text Full Text (PDF) All Versions of this Article: 109/10/1215    most recent 01.CIR.0000121427.53291.78v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Higashi, Y. Articles by Yoshizumi, M. Search for Related Content PubMed PubMed Citation Articles by Higashi, Y. Articles by Yoshizumi, M. Related Collections Other arteriosclerosis Other Treatment

(Circulation. 2004;109:1215-1218.)
© 2004 American Heart Association, Inc.

Brief Rapid Communications

Autologous Bone-Marrow Mononuclear Cell Implantation Improves Endothelium-Dependent Vasodilation in Patients With Limb Ischemia

Yukihito Higashi, MD; Masashi Kimura, MD; Keiko Hara, MD; Kensuke Noma, MD; Daisuke Jitsuiki, MD; Keigo Nakagawa, MD; Tetsuya Oshima, MD; Kazuaki Chayama, MD; Taijiro Sueda, MD; Chikara Goto, RTP, MS; Hiroaki Matsubara, MD; Toyoaki Murohara, MD; Masao Yoshizumi, MD

From the Department of Cardiovascular Physiology and Medicine (Y.H., M.Y.), Department of Medicine and Molecular Science (M.K., K.H., K. Noma, D.J., K. Nakagawa, K.C.), Division of Physical Therapy, Institute of Health Sciences (C.G.), and the Department of Clinical Laboratory Medicine (T.O.), Department of Surgery (T.S.), Hiroshima University Graduate School of Biomedical Sciences, Department of Cardiovascular Medicine (H.M.), Kyoto Prefectural University of Medicine, and Department of Cardiology (T.M.), Nagoya University Graduate School of Medicine.

Correspondence to Yukihito Higashi, MD, PhD, FAHA, Department of Cardiovascular Physiology and Medicine, Graduate School of Biomedical Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan. E-mail yhigashi{at}hiroshima-u.ac.jp

Received March 5, 2003; de novo received December 15, 2003; revision received January 28, 2003; accepted January 28, 2003.

Background— Patients with limb ischemia were associated with endothelial dysfunction. The purpose of this study was to determine whether autologous bone-marrow mononuclear cell (BM-MNC) implantation improves endothelial dysfunction in patients with limb ischemia.

Methods and Results— We evaluated the leg blood flow (LBF) response to acetylcholine (ACh), an endothelium-dependent vasodilator, and sodium nitroprusside (SNP), an endothelium-independent vasodilator, before and after BM-MNC implantation in 7 patients with limb ischemia. LBF was measured with a mercury-filled Silastic strain-gauge plethysmograph. The number of BM-MNCs implanted into ischemic limbs was 1.6x10⁹±0.3x10⁹. The number of CD34⁺ cells included in the implanted BM-MNCs was 3.8x10⁷±1.6x10⁷. BM-MNC implantation improved the ankle-brachial pressure index (0.33±0.21 to 0.39±0.17, P=0.06), transcutaneous oxygen pressure (28.4±11.5 to 36.6±5.2 mm Hg, P=0.03), and pain-free walking time (0.8±0.6 to 2.9±2.2 minutes, P=0.02). After BM-MNC implantation, LBF response to ACh was enhanced (19.3±6.8 versus 29.6±7.1 mL/min per 100 mL; P=0.002). The vasodilatory effect of SNP was similar before and after BM-MNC implantation.

Conclusions— These findings suggest that BM-MNC implantation augments endothelium-dependent vasodilation in patients with limb ischemia.

Key Words: angiogenesis • cells • endothelium • ischemia

This article has been cited by other articles:

				Z. Boda, M. Udvardy, K. Razso, K. Farkas, J. Toth, L. Jambor, Z. Olah, P. Ilonczai, M. Szarvas, J. Kappelmayer, et al. Stem Cell Therapy: A Promising and Prospective Approach in the Treatment of Patients With Severe Buerger's Disease Clinical and Applied Thrombosis/Hemostasis, October 1, 2009; 15(5): 552 - 560. [Abstract] [PDF]

				Q. Liu, Z. Chen, T. Terry, J. M. McNatt, J. T. Willerson, and P. Zoldhelyi Intra-Arterial Transplantation of Adult Bone Marrow Cells Restores Blood Flow and Regenerates Skeletal Muscle in Ischemic Limbs Vascular and Endovascular Surgery, October 1, 2009; 43(5): 433 - 443. [Abstract] [PDF]

				K. I. Paraskevas, C. Psathas, T. Dragios, D. G. Chatzis, D. P. Mikhailidis, and Z. S. Kyriakides The Impact of Novel Treatment Modalities on the Therapeutic Approach of Cardiovascular Diseases Angiology, February 1, 2009; 60(1): 5 - 7. [PDF]

				I. Al Mheid and A. A. Quyyumi Cell Therapy in Peripheral Arterial Disease Angiology, January 1, 2009; 59(6): 705 - 716. [Abstract] [PDF]

				T. Nevskaya, L. Ananieva, S. Bykovskaia, I. Eremin, E. Karandashov, J. Khrennikov, E. Mach, M. Zaprjagaeva, N. Guseva, and E. Nassonov Autologous progenitor cell implantation as a novel therapeutic intervention for ischaemic digits in systemic sclerosis Rheumatology, January 1, 2009; 48(1): 61 - 64. [Abstract] [Full Text] [PDF]

				T. Sugiura, T. Kondo, Y. Kureishi-Bando, Y. Numaguchi, O. Yoshida, Y. Dohi, G. Kimura, R. Ueda, T. J. Rabelink, and T. Murohara Nifedipine Improves Endothelial Function: Role of Endothelial Progenitor Cells Hypertension, September 1, 2008; 52(3): 491 - 498. [Abstract] [Full Text] [PDF]

				R. P.W. Rouhl, R. J. van Oostenbrugge, J. Damoiseaux, J.-W. C. Tervaert, and J. Lodder Endothelial Progenitor Cell Research in Stroke: A Potential Shift in Pathophysiological and Therapeutical Concepts Stroke, July 1, 2008; 39(7): 2158 - 2165. [Abstract] [Full Text] [PDF]

				C Kalka and I. Baumgartner Gene and stem cell therapy in peripheral arterial occlusive disease Vascular Medicine, May 1, 2008; 13(2): 157 - 172. [Abstract] [PDF]

				K. Kendziorra, H. Barthel, S. Erbs, F. Emmrich, R. Hambrecht, G. Schuler, O. Sabri, and R. Kluge Effect of Progenitor Cells on Myocardial Perfusion and Metabolism in Patients After Recanalization of a Chronically Occluded Coronary Artery J. Nucl. Med., April 1, 2008; 49(4): 557 - 563. [Abstract] [Full Text] [PDF]

				Y. Hasegawa, T. Ogihara, T. Yamada, Y. Ishigaki, J. Imai, K. Uno, J. Gao, K. Kaneko, H. Ishihara, H. Sasano, et al. Bone Marrow (BM) Transplantation Promotes {beta}-Cell Regeneration after Acute Injury through BM Cell Mobilization Endocrinology, May 1, 2007; 148(5): 2006 - 2015. [Abstract] [Full Text] [PDF]

				S. Wassmann, N. Werner, T. Czech, and G. Nickenig Improvement of Endothelial Function by Systemic Transfusion of Vascular Progenitor Cells Circ. Res., October 13, 2006; 99(8): E74 - E83. [Abstract] [Full Text] [PDF]

				J. Emmerich Current State and Perspective on Medical Treatment of Critical Leg Ischemia: Gene and Cell Therapy International Journal of Lower Extremity Wounds, December 1, 2005; 4(4): 234 - 241. [Abstract] [PDF]

				C. Napoli, S. Williams-Ignarro, F. de Nigris, G. de Rosa, L. O. Lerman, B. Farzati, A. Matarazzo, G. Sica, C. Botti, A. Fiore, et al. Beneficial effects of concurrent autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the mouse hindlimb PNAS, November 22, 2005; 102(47): 17202 - 17206. [Abstract] [Full Text] [PDF]

				S. Erbs, A. Linke, V. Adams, K. Lenk, H. Thiele, K.-W. Diederich, F. Emmrich, R. Kluge, K. Kendziorra, O. Sabri, et al. Transplantation of Blood-Derived Progenitor Cells After Recanalization of Chronic Coronary Artery Occlusion: First Randomized and Placebo-Controlled Study Circ. Res., October 14, 2005; 97(8): 756 - 762. [Abstract] [Full Text] [PDF]

				T. Iwase, N. Nagaya, T. Fujii, T. Itoh, S. Murakami, T. Matsumoto, K. Kangawa, and S. Kitamura Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia Cardiovasc Res, June 1, 2005; 66(3): 543 - 551. [Abstract] [Full Text] [PDF]